Jieyi Wang

Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade

Haidong Tang, Yang Wang, Lukasz K. Chlewicki et al. · Cancer Cell · 2016 · 482 citations · Full text

Medicine, Immunology, Oncology +16

ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both <i>MET</i> –Amplified and c-Met–Overexpressing Tumors, Irrespective of <i>MET</i> Pathway Dependence

Jieyi Wang, Mark G. Anderson, Anatol Oleksijew et al. · Clinical Cancer Research · 2016 · 140 citations · Full text

Medicine, Oncology, Pharmacology +16

Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity

Xinyue Qi, Fanlin Li, Yi Wu et al. · Nature Communications · 2019 · 133 citations · Full text

Pharmacy, Immunology, Oncology +17

Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification

Jieyi Wang, Liliane Goetsch, Lora A. Tucker et al. · BMC Cancer · 2016 · 63 citations · Full text

Medicine, Cancer Biology, Oncology +16

Discovery and Optimization of Anthranilic Acid Sulfonamides as Inhibitors of Methionine Aminopeptidase-2:  A Structural Basis for the Reduction of Albumin Binding

George S. Sheppard, Jieyi Wang, Megumi Kawai et al. · Journal of Medicinal Chemistry · 2006 · 61 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14